Pharvaris (PHVS) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Morgan Conn, Ph.D., the Chief Business Officer of Pharvaris N.V., has voluntarily resigned as of October 4, 2024, to seek new opportunities, without any disagreements with the company. His duties at the pharmaceutical firm will be distributed among the existing members of the executive committee. This corporate update could influence the company’s stock as investors monitor the reallocation of responsibilities within Pharvaris’s leadership team.
For further insights into PHVS stock, check out TipRanks’ Stock Analysis page.
